Log in
10.11.2025

Deal of the Week |

Calendar Week # 45 |

2025

Italian biotech AAVantgarde adds $141M series B to fund retinal disease gene therapy trials

  • HQ: IT

Founded: 2021

  • Series B
  • Sector: Biotechnology

Investment Raised: USD 141m €

Valuation Remains Undisclosed

Investors: The raise was led by Atlas Venture, Forbion and a new backer in the form of Schroders. Other new investors who participated in the round include Amgen Ventures, Athos Capital, CDP Venture Capital, Columbia IMC, Neva SGR, Sixty Degree Capital, XGen Venture and Willett Advisors.

News Link
06.11.2025

Deal of the Month |

October |

2025

Munich-based Tubulis secures €308 million to advance antibody-drug conjugate innovation

  • HQ: DE

Founded: 2012

  • Series C
  • Sector: Biotechnology

Investment Raised: EUR 308m €

Valuation Remains Undisclosed

Investors: Led by Venrock Healthcare Capital Partners, with participation from Wellington Management and Ascenta Capital, alongside existing investors including Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, OCCIDENT, Seventure Partners, and HTGF.

News Link
20.10.2025

Deal of the Week |

Calendar Week # 42 |

2025

Munich-based Tubulis secures €308 million to advance antibody-drug conjugate innovation

  • HQ: DE

Founded: 2012

  • Series C
  • Sector: Biotechnology

Investment Raised: EUR 308m €

Valuation Remains Undisclosed

Investors: Led by Venrock Healthcare Capital Partners, with participation from Wellington Management and Ascenta Capital, alongside existing investors including Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, OCCIDENT, Seventure Partners, and HTGF.

News Link
04.08.2025

Deal |

2025

Sava lands $19M for world-first biosensor to disrupt real-time health monitoring

  • HQ: UK

Founded: 2016

  • Series A
  • Sector: Biotechnology

Investment Raised: GBP 14.2m €

Valuation Remains Undisclosed

Investors: Athletico Ventures, Balderton Capital, Exceptional Ventures, Italian Founders Fund, JamJar Investments, Norrsken VC, Pentland Ventures, True.

News Link
30.06.2025

Deal |

2025

Oncorena’s new issue of shares fully subscribed

  • HQ: SE

Founded: 2011

  • Venture – Series Unknown
  • Sector: Biotechnology

Investment Raised: SEK 133m €

Valuation Remains Undisclosed

Investors: HealthCap, Linc

News Link
17.06.2025

Deal |

2025

Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma

  • HQ: FR

Founded: 2012

  • Venture – Series Unknown
  • Sector: Biotechnology

Investment Raised: USD 19m €

Valuation Remains Undisclosed

Investors: Institute for Follicular Lymphoma Innovation, Lundbeckfonden Ventures, Primo Capital, Seventure Partners, SymBiosis, The Leukemia & Lymphoma Society’s Therapy Acceleration Program

News Link
17.06.2025

Deal |

2025

SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines

  • HQ: ES

Founded: 2012

  • Series B
  • Sector: Biotechnology

Investment Raised: USD 135m €

Valuation Remains Undisclosed

Investors: Asabys Partners, EQT Life Sciences, Gilde Healthcare, New Enterprise Associates, Novartis Venture Fund, Roche Venture Fund, Sanofi Ventures, UCB Ventures, Ysios Capital

News Link
02.06.2025

Deal of the Week |

Calendar Week # 22 |

2025

GlycoEra raises USD 130 Million Series B to advance targeted autoimmune therapies

  • HQ: CH

Founded: 2020

  • Series B
  • Sector: Biotechnology

Investment Raised: USD 130m €

Valuation Remains Undisclosed

Investors: 5AM Ventures, Agent Capital, Bristol-Myers Squibb, Catalio Capital Management, LifeArc Ventures, MP Healthcare Venture Management, Novo Holdings, Qatar Investment Authority, Roche Venture Fund, Sixty Degree Capital, Sofinnova Partners

News Link
02.06.2025

Deal |

2025

Salvia BioElectronics lands $60M to take on Medtronic, Boston Scientific, and Abbott with its migraine implant

  • HQ: NL

Founded: 2017

  • Series B
  • Sector: Biotechnology

Investment Raised: USD 60m €

Valuation Remains Undisclosed

Investors: BOM, Dolby Family Ventures, European Innovation Council Fund, Inkef, Innovation Industries, Invest-NL, Panakes Partners, SHS Capital, Thuja Capital

News Link
22.05.2025

Deal |

2025

CellCentric lands $120M to power clinical trials of oral cancer drug inobrodib

  • HQ: UK

Founded: 2003

  • Series C
  • Sector: Biotechnology

Investment Raised: USD 120m €

Valuation Remains Undisclosed

Investors: Avego Bioscience Capital, BrightEdge - American Cancer Society, Forbion Capital Partners, RA Capital Management

News Link
22.05.2025

Deal |

2025

Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health

  • HQ: CH

Founded: 2021

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 65m €

Valuation Remains Undisclosed

Investors: ALSA Ventures, AXA Investment Managers, Jeito Capital, M Ventures, Ysios Capital

News Link
16.05.2025

Deal |

2025

Azafaros, Jeito, Seroba, TILT Biotherapeutics, Eligo Bioscience

  • HQ: NL

Founded: 2018

  • Series B
  • Sector: Biotechnology

Investment Raised: EUR 132m €

Valuation Remains Undisclosed

Investors: BioGeneration Ventures, Forbion Capital Partners, Jeito Capital, Pictet Alternative Advisors, Schroders Capital, Seroba Life Sciences

News Link
09.05.2025

Deal |

2025

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

  • HQ: CH

Founded: 2017

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 65m €

Valuation Remains Undisclosed

Investors: +ND Capital, 4See Ventures, Alexandria Venture Investments, Apollo Health Ventures, ATHOS, Bernina BioInvest, Earlybird Venture Capital, Eli Lilly, LifeLink Ventures, Longview Ventures, Schroders Capital, Sofinnova Partners

News Link
04.04.2025

Deal |

2025

Ecoat secures €21 million to reinvent the future of paint – sustainably

  • HQ: FR

Founded: 2011

  • Venture – Series Unknown
  • Sector: Biotechnology

Investment Raised: EUR 18m €

Valuation Remains Undisclosed

Investors: Starquest Capital, Yotta Capital Partners

News Link
27.03.2025

Deal |

2025

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round

  • HQ: BE

Founded: 2019

  • Series A
  • Sector: Biotechnology

Investment Raised: EUR 77.7m €

Valuation Remains Undisclosed

Investors: AdBio partners, Asabys Partners, CMT Research Foundation, Eli Lilly, Gemma Frisius Fund, Jeito Capital, Newton Biocapital, Novo Holdings, PMV, V-Bio Ventures, VIB

News Link
14.03.2025

Deal |

2025

Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding

  • HQ: IE

Founded: 2018

  • Venture – Series Unknown
  • Sector: Biotechnology

Investment Raised: EUR 22m €

Valuation Remains Undisclosed

Investors: EarlyBird, EQT Life Sciences, Seroba Life Sciences, SV Health Investors

News Link
14.03.2025

Deal |

Valo Therapeutics announces EUR 19m of investment funding and expanded clinical trials

  • HQ: FI

Founded: 2016

  • Venture – Series Unknown
  • Sector: Biotechnology

Investment Raised: EUR 19m €

Valuation Remains Undisclosed

Investors: CDP Venture Capital, ENEA Tech e Biomedical, Freeman Road, Indaco Venture Partners

News Link
27.02.2025

Deal |

2025

EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform development

  • HQ: FR

Founded: 2019

  • Series B
  • Sector: Biotechnology

Investment Raised: EUR 27m €

Valuation Remains Undisclosed

Investors: Andera Partners, Bpifrance, SCI Ventures

News Link
19.02.2025

Deal |

2025

Exclusive: Lux leads $25M Series A in a Lithuanian startup plotting US expansion

  • HQ: LT

Founded: 2016

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 25m €

Valuation Remains Undisclosed

Investors: Lux Capital

News Link
05.02.2025

Deal |

2025

DeepTech startup Enduro Genetics raises €12 million to unlock the future of scalable bioproduction

  • HQ: DK

Founded: 2019

  • Series A
  • Sector: Biotechnology

Investment Raised: EUR 12m €

Valuation Remains Undisclosed

Investors: NOON Ventures, Sandwater, Supernova Invest

News Link
31.01.2025

Deal of the Month |

January |

2025

Bioptimus raises $41M to develop a ‘GPT for biology’

  • HQ: FR

Founded: 2024

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 41m €

Valuation Remains Undisclosed

Investors: Cathay Innovation

News Link
15.01.2025

Deal of the Week |

Calendar Week # 3 |

2025

Bioptimus raises $41M to develop a ‘GPT for biology’

  • HQ: FR

Founded: 2024

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 41m €

Valuation Remains Undisclosed

Investors: Cathay Innovation

News Link
13.01.2025

Deal |

2025

EconomistesBAN lidera una ronda de €347.000 en Phoenix Foods, startup catalana especializada en insecticultura

  • HQ: ES

Founded: 2023

  • Seed
  • Sector: Biotechnology

Investment Raised: EUR 347k €

Valuation Remains Undisclosed

Investors: Economistes BAN

News Link
10.01.2025

Deal |

2025

Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases

  • HQ: NL

Founded: 2021

  • Series A
  • Sector: Biotechnology

Investment Raised: EUR 65m €

Valuation Remains Undisclosed

Investors: Droia Ventures, Frazier Life Sciences, Novartis Venture Fund, RTW Investments, RV Invest, SSI Strategy, Thuja Capital

News Link
10.01.2025

Deal |

2025

Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing

  • HQ: CH

Founded: 2011

  • Series C
  • Sector: Biotechnology

Investment Raised: CHF 50m €

Valuation Remains Undisclosed

Investors: BlackRock, BVF Partners, Cormorant Asset Management, Forbion Capital Partners, HBM Healthcare Investments, Novo Holdings, Octagon Capital Advisors, RTW Investments

News Link
10.01.2025

Deal |

2025

Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines

  • HQ: FR

Founded: 2014

  • Series A
  • Sector: Biotechnology

Investment Raised: EUR 32m €

Valuation Remains Undisclosed

Investors: Bpifrance, Fund+, Invus, Kurma Partners, Novo Holdings, Omnes Capital, Seroba Life Sciences, Turenne Capital, UI Investissement

News Link
27.12.2024

Deal |

2024

Carbon-negative protein production startup Arborea raises €5 million

  • HQ: UK

Founded: 2015

  • Venture – Series Unknown
  • Sector: Biotechnology

Investment Raised: EUR 5m €

Valuation Remains Undisclosed

Investors: Banco Portugues de Fomento, Indico Capital Partners

News Link
22.11.2024

Deal |

2024

ATB Therapeutics Raises €54M in Series A Funding

  • HQ: BE

Founded: 2018

  • Series A
  • Sector: Biotechnology

Investment Raised: EUR 54m €

Valuation Remains Undisclosed

Investors: EQT Life Sciences, MRL Ventures Fund, Sambrinvest, SFPIM, V-Bio Ventures, VIVES Funds, WE International

News Link
13.11.2024

Deal |

2024

Novo Holdings, OrbiMed, Jeito lead $181M fundraise for ADC biotech

  • HQ: CH

Founded: 2019

  • Series D
  • Sector: Biotechnology

Investment Raised: USD 181.4m €

Valuation Remains Undisclosed

Investors: Avego Bioscience Capital, Bpifrance, Catalio Capital Management, Frazier Life Sciences, Jeito Capital, Longitude Capital, Morningside Venture Investments, Novo Holdings, OrbiMed, Piper Heartland Healthcare Capital, Pureos Bioventures, RA Capital Management

News Link
30.10.2024

Deal of the Week |

Calendar Week # 44 |

2024

Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-Focused Pipeline

  • HQ: BE

Founded: 2017

  • Series D
  • Sector: Biotechnology

Investment Raised: EUR 82.1m €

Valuation Remains Undisclosed

Investors: Invus, Sanofi

News Link